Bloodstream infections in cystic fibrosis: Nine years of experience in both adults and children

Journal of Cystic Fibrosis

Volumn 11, Issue 4, 2012, Pages 337-339

  Cargill, James ^a   Etherington, Christine ^b   Peckham, Daniel ^b   Conway, Steven ^b,c   Denton, Miles ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Bloodstream; Infection; Outcomes

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ATTRIBUTABLE RISK; BACTERIAL VIRULENCE; BLOOD CULTURE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANDIDA; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTAMINATION; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; HUMAN; LOWER RESPIRATORY TRACT; LOWER RESPIRATORY TRACT INFECTION; MULTICENTER STUDY; OUTCOME ASSESSMENT; PEDIATRICS; RETROSPECTIVE STUDY; RISK FACTOR; STENOTROPHOMONAS MALTOPHILIA; TOTALLY IMPLANTABLE VASCULAR ACCESS DEVICE; VASCULAR ACCESS DEVICE;

ADULT; BACTEREMIA; CANDIDIASIS; CATHETERS, INDWELLING; CHILD; CYSTIC FIBROSIS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS;

EID: 84862503122     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.02.004     Document Type: Article

References (12)

1. McCarthy M.M., Rourk M.H., Spock A. Bacteremia in patients with cystic fibrosis. Clinic Pediatr 1980, 19:746-748.
2. Rosenstein B.J., Hall D.E. Pneumonia and septicemia due to Pseudomonas cepacia in a patient with cystic fibrosis. John Hopkins Med J 1980, 147:188-189.
3. Stead R.J., Davidson T.I., Duncan F.R., Hodson M.E., Batten J.C. Use of a totally implantable system for venous access in cystic fibrosis. Thorax 1987, 42:149-150.
4. Essex-Carter A., Gilbert J., Robinson T., Littlewood J.M. Totally implantable venous access systems in paediatric practice. Arch Dis Child 1989, 64:119-123.
5. Kariyawasam H.H., Pepper J.P., Hodson M.E., Geddes D.M. Experience of totally implantable venous access devices (TIVADs) in adults with cystic fibrosis over a 13-year period. Respir Med 2000, 94:1161-1165.
6. Munck A., Malbezin S., Bloch J., Gerardin M., Lebourgeois M., et al. Follow-up of 452 totally implantable vascular devices in cystic fibrosis patients. Eur Respir J 2004, 23:430-434.
7. Royle T.J., Davies R.E., Gannon M.X. Totally implantable venous access devices-20 years' experience of implantation in cystic fibrosis patients. Ann R Coll Surg Engl 2008, 90:679-684.
8. Horn C.K., Conway S.P. Candidaemia: risk factors in patients with cystic fibrosis who have totally implantable venous access systems. J Infect 1993, 26:127-132.
9. Mermel L.A., Allon M., Bouza E., Craven D.E., Flynn P., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
10. Ratnalingam R.A., Peckham D., Denton M., Kerr K., Conway S. Stenotrophomonas maltophilia bacteraemia in two patients with cystic fibrosis associated with totally implantable venous access devices. J Infect 2002, 44:53-55.
11. Blackburn L., Brownlee K., Conway S., Denton M. 'Cepacia syndrome' with Burkholderia multivorans, 9years after initial colonization. J Cyst Fibros 2004, 2:220-221.
12. Blot F., Nitenberg G., Chachaty E., Raynard B., Germann N., et al. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet 1999, 354:1071-1077.